Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Shanghai Haixin Group Co Ltd

Shanghai Haixin Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)6.12
  • Today's Change0.12 / 2.00%
  • Shares traded7.33m
  • 1 Year change-13.19%
  • Beta1.2086
Data delayed at least 15 minutes, as of Nov 06 2024 03:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Haixin Group Co., Ltd. is a China based company principally engaged in the production and sales of textile products and pharmaceuticals. The Company operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The Company operates its business in the domestic market and overseas markets.

  • Revenue in CNY (TTM)841.27m
  • Net income in CNY178.76m
  • Incorporated1993
  • Employees760.00
  • Location
    Shanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
  • Phone+86 2 163917000
  • Fax+86 2 163917678
  • Websitehttp://www.haixin.com.cn
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shouyao Holdings Co Ltd4.03m-209.50m4.98bn185.00--5.79--1,236.51-1.41-1.410.02715.790.00380.16165.0321,779.19-19.57-37.24-21.64-42.6395.4896.03-5,199.60-2,251.777.06--0.0087--186.18-23.51-6.76--34.59--
Sinotherapeutics Inc449.12m109.57m5.00bn260.0045.684.05--11.140.24170.24170.99072.730.32282.505.201,727,366.007.88--8.54--53.66--24.40--7.95--0.00002--21.13---34.29------
Hainan Huluwa Pharmaceutical Grop Co Ltd1.82bn112.88m5.17bn2.47k45.764.47--2.840.28210.28214.552.890.63232.493.22737,841.704.095.816.249.7853.9158.016.487.030.757312.480.531621.7425.7514.1324.291.1646.37--
Shanghai Haixin Group Co Ltd841.27m178.76m5.40bn760.0040.321.65--6.420.14810.14810.6973.620.16075.096.891,106,933.004.062.684.523.0652.4444.5525.2511.173.01--0.007736.10-17.881.481.204.19-10.2713.18
Hunan Fangsheng Pharmaceutical Co Ltd1.76bn272.96m5.42bn1.69k19.783.40--3.080.62440.62444.053.630.55131.436.701,044,835.008.345.3914.839.3769.2866.9115.128.950.4736--0.316146.47-9.129.15-34.6420.6823.914.75
Guizhou Sanli Pharmaceutical Co Ltd2.11bn328.87m5.79bn2.28k18.133.62--2.740.77980.77985.053.910.83722.904.48925,761.2013.3212.3919.8816.7269.3770.4515.9116.311.62--0.237325.7036.1017.7545.4221.51127.48--
Data as of Nov 06 2024. Currency figures normalised to Shanghai Haixin Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.24%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 2024842.30k0.11%
Gfund Management Co., Ltd.as of 30 Jun 2024379.00k0.05%
China Asset Management Co., Ltd.as of 30 Jun 2024228.10k0.03%
Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024133.70k0.02%
China Southern Asset Management Co., Ltd.as of 30 Jun 202445.10k0.01%
Penghua Fund Management Co., Ltd.as of 30 Jun 202440.60k0.01%
Sealand Securities Co., Ltd. (Investment Management)as of 30 Jun 202434.40k0.01%
Hongde Fund Management Co., Ltd.as of 30 Jun 202434.10k0.01%
Vanguard Global Advisers LLCas of 30 Sep 202424.20k0.00%
Tebon Fund Management Co. Ltd.as of 30 Jun 202412.10k0.00%
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.